Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedNew help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label has been updated. The study's recruitment status is now shown as 'No longer looking for participants,' and a new revision entry 'Revision: v3.6.0' has been introduced.SummaryDifference0.5%

- Check9 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, reflecting an update to the page's metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a revised version number (v3.5.4) replacing v3.5.3, indicating a deployment or patch without altering the displayed study information.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer updates the ClinicalTrials.gov release “Revision” number from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision metadata updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.